2. INTRODUCTION
• A brain abscess (or cerebral abscess) is a focal collection within the
brain parenchyma which can arise as a complication of a variety of
infections, trauma, or surgery.
• It results from inflammation and collection of infected material,
coming from local (ear infection, dental abscess, infection of
paranasal sinuses, infection of the mastoid air cells of the temporal
bone, epidural abscess) or remote (lung, heart, kidney etc.) infectious
sources, within the brain tissue.
4. EPIDEMIOLOGY
• Brain abscesses are rare in developed countries but are a significant
problem in developing countries.
• Brain abscesses are more common in males than in females.
• Brain abscesses occur more frequently in the first 4 decades of life.
5. ETIOLOGY
The microbial etiology of brain abscess depends on the
• patient's age,
• site of primary infection, and
• the patient's immune status.
6. ETIOLOGY cont’d
• A significant number of brain abscesses are polymicrobic but the
most common agents are bacterial.
• The predominant organisms include the following:
• Staphylococcus aureus, including methicillin-resistant
• Streptococcus viridans
• Anerobic bacteria
• Etc
7. ETIOLOGY cont’d
• The incidence of fungal brain abscess has been rising as a result of
increased use of corticosteroid therapy, broad-spectrum antimicrobial
therapy, and immunosuppressive agents. Common agents include
• Aspergillus, Candida, Cryptococcus
• Other agents are
• Protozoa e.g. Toxoplasma gondii
• Helminths e.g. Taenia solium
• Co-infection with bacterial, viral, and fungal organisms can occur.
8. PATHOPHYSIOLOGY
• Brain abscess is caused by intracranial inflammation secondary to
infection with subsequent abscess formation.
• Infection may enter the intracranial compartment directly or
indirectly via 3 routes
• Contiguous suppurative focus
• Hematogenous spread from a distant focus
• Trauma
9. PATHOPHYSIOLOGY cont’d
The process of abscess formation occurs in four stages-
• Early cerebritis (days 1–3)
• Late cerebritis (days 4–9)
• Early capsule formation (days 10–13)
• Late capsule formation (>14 days)
10. CLINICAL FEATURES- History
• Most symptoms are a result of the size and location of the space-
occupying lesion or lesions.
• The frequency of common symptoms and signs is as follows:
• Headache - 70%
• Mental status changes (may indicate cerebral edema) - 65%
• Focal neurologic deficits - 65%
• Fever - 50%
• Seizures - 25-35%
• Nausea and vomiting - 40%
• Nuchal rigidity - 25%
• Papilledema - 25%
11. CLINICAL FEATURES- Examination
• On examination, the following signs might be present-
• Low-grade or high-grade fever
• Confusion
• Stupor
• Focal motor or sensory impairments
• General or focal seizures
• Papilledema
• Ataxia
• Hemiparesis
• Neck stiffness
12. INVESTIGATIONS
• FBC count with differential
• Erythrocyte sedimentation rate (ESR)
• Serum C-reactive protein (CRP)
• Serological tests for some pathogens
• Blood cultures for aerobic and anerobic bacteria (at least 2; preferably
before antibiotic usage)
• Abscess aspirate
• Culture
• Histopathological examination
• Lumbar puncture is rarely warranted
15. TREATMENTS
• Medical
• Abscesses in a deep or dominant location
• The presence of coexisting meningitis or ependymitis
• Early reduction of abscess with clinical improvement after antimicrobial
therapy
• Abscess size less than 2.5 cm
• Surgical
• Significant mass effect exerted by lesion
• Proximity to ventricles
• Evidence of significant increased intracranial pressure
• Traumatic abscess associated with foreign material
16. TREATMENTS
• Larger than 2.5 cm – excision
• Smaller than 2.5 cm – aspiration for definitive diagnosis
• Empirical ATB – metronidazole + third-generation cephalosporin
• Once the infecting pathogen is isolated, antimicrobial therapy can be
modified for optimal treatment
• Antibiotics optimal duration is about 6 to 8 wks IV followed by oral
antibiotics for 2 to 3 months.
17. TREATMENTS
Surgical therapy –
• Aspiration after bur-hole placement
• Stereotactic aspiration
• Complete excision by craniotomy
18. COMPLICATIONS
• Rupture of abscess into ventricles or subarachnoid space.
• Recurrence of abscess
• Uncal or tonsillar herniation due to increased intracranial pressure
• Long-term neurologic sequelae in 50 percent of patients e.g.
hemiparesis, seizures, etc.
19. PROGNOSIS
• The mortality rate from brain abscess is currently approximately 10%
• However, if the abscess ruptures into the ventricular system, the
mortality rate may be 80%.
• Morbidity in survivors is generally due to residual neurologic defects,
increased incidence of seizures due to scar tissue foci, or
neuropsychiatric changes.
Contiguous suppurative focus
Direct extension may occur from necrotic areas of osteomyelitis in the posterior wall of the frontal sinus, the sphenoid and ethmoid sinuses, mandibular dental infections, as well as from subacute and chronic otitis media and mastoiditis. Usually causes a single brain abscess.
Hematogenous spread from a distant focus
Frequently found in the distribution of the middle cerebral artery. The most common effected lobes (in descending frequency) are the fontal, temporal, parietal, cerebellar, and occipital. These abscesses are more commonly multiple and multiloculated.
Hematogenous spread is associated with cyanotic heart disease (mostly in children), pulmonary arteriovenous malformations, endocarditis, chronic lung infections (eg, abscess, empyema, bronchiectasis), skin infections, abdominal and pelvic infections, neutropenia, transplantation, esophageal dilatation, injection drug use, and HIV infection.
Trauma
Trauma that causes an open skull fracture allows organisms to seed directly in the brain.
Brain abscess can also occur as a complication of intracranial surgery, and foreign body, such as pencil tip, lawn dart, bullets, and shrapnel.
The early stage of brain abscess (first 7-14 days) is called cerebritis and is associated
with edema. Necrosis and liquefaction occur after 2-3 weeks, and the lesion becomes
gradually surrounded by a fibrotic capsule
Early cerebritis- days 1–3
Acute inflammatory cells, bacteria present on Gram stain
Rapid perivascular infiltration of neutrophils, plasma cells and mononuclear cells
Reticulin formation begins
Marked cerebral edema
Late cerebritis- days 4–9
Enlarging necrotic center reaching maximum size
Inflammatory cells
Maximal extent of cerebritis, rapid increase in new vessel formation
Appearance of fibroblast with rapid formation of reticulin
Prominent cerebral edema
Appearance of reactive astrocyte
Early capsule formation- days 10–13
Decrease in necrotic center
Increased numbers of fibroblasts and macrophages
Maximal degree of neovascularity
Evolution of mature collagen
Regression of cerebral edema
Increase in reactive astrocyte
Late capsule formation
Further decrease in necrotic center
Further increase in fibroblasts
Cerebritis restricted to outside of collagen capsule
Reduced neovascularity
Capsule completed by end of second week
Regression of cerebral edema
Marked gliosis/ outside capsule by end of third week
Moderate leukocytosis is present, and the ESR and CRP level are generally elevated. Serum sodium levels may be low because of inappropriate antidiuretic hormone production. Platelet counts may be high or low.
Serological tests for some pathogens (eg, serum immunoglobulin G antibodies,
CSF polymerase chain reaction [PCR] for Toxoplasma)
Blood cultures for aerobic and anerobic bacteria (at least 2; preferably before antibiotic usage)
Lumbar puncture is rarely warranted and is contraindicated if increased intracranial pressure is present because of the potential for CNS herniation and death.